Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced disease
(Q33454076)
scientific article
scientific article
Language:
Current Data About
Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced disease
other details
description | scientific article |
External Links
(P356) |
10.1038/BJC.1987.85
|
(P698) |
3580266
|
(P932) |
2001703
|
(P5875) |
19582194
|
(P6179) |
1027250541
|